Ruchun Ji

Ruchun Ji

August 22, 2019 | The Recorder

Crossing the International Dateline: US-China Life Sciences Transactions

Despite the trade-related headwinds, the question for U.S. life sciences companies is not whether to engage with China—but how?

By Thomas Duley and Ruchun Ji

7 minute read